ResearcherTUM KlinikumActive in the last 2 years
Katrin J. Frank
Matched on OpenAlex author ID A5042550490. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT. Co-author DOI 10.1186/s12943-025-02486-5↗
- Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2022.100815↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marina Lesina · 2 shared papers, 2022–2025 · strength 0.28
- Paper c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance an… DOI 10.1186/s12943-025-02486-5↗
- Paper Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pan… DOI 10.1016/j.xcrm.2022.100815↗
- Kıvanç Görgülü · 2 shared papers, 2022–2025 · strength 0.28
- Paper c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance an… DOI 10.1186/s12943-025-02486-5↗
- Paper Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pan… DOI 10.1016/j.xcrm.2022.100815↗
- Dietrich Alexander Ruess · 2 shared papers, 2022–2025 · strength 0.28
- Paper c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance an… DOI 10.1186/s12943-025-02486-5↗
- Paper Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pan… DOI 10.1016/j.xcrm.2022.100815↗
- Bruno Sáinz · 2 shared papers, 2022–2025 · strength 0.28
- Paper c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance an… DOI 10.1186/s12943-025-02486-5↗
- Paper Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pan… DOI 10.1016/j.xcrm.2022.100815↗
- Hana Algül · 2 shared papers, 2022–2025 · strength 0.28
- Paper c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance an… DOI 10.1186/s12943-025-02486-5↗
- Paper Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pan… DOI 10.1016/j.xcrm.2022.100815↗
- Katja Peschke · 1 shared paper, 2025 · strength 0.16
- Jiaoyu Ai · 1 shared paper, 2025 · strength 0.16
- Derya Bakırdöğen · 1 shared paper, 2025 · strength 0.16
- María Jesús Fernández‐Aceñero · 1 shared paper, 2025 · strength 0.16
- Nan Wu · 1 shared paper, 2025 · strength 0.16
- Sonia Alcalá · 1 shared paper, 2025 · strength 0.16
- Raphela A. Ranjan · 1 shared paper, 2025 · strength 0.16
- Maximilian Reichert · 1 shared paper, 2025 · strength 0.16
- Harun Öztürk · 1 shared paper, 2025 · strength 0.16
- Juan Carlos López-Gil · 1 shared paper, 2025 · strength 0.16
- Roland Michael Schmid · 1 shared paper, 2025 · strength 0.16
- Mazhar Adli · 1 shared paper, 2025 · strength 0.16
- İhsan Ekin Demir · 1 shared paper, 2025 · strength 0.16
- Javier Martínez‐Useros · 1 shared paper, 2025 · strength 0.16
- Wolfgang Weber · 1 shared paper, 2022 · strength 0.11
- Derya Kabacaoğlu · 1 shared paper, 2022 · strength 0.11
- Antonio Mulero‐Sánchez · 1 shared paper, 2022 · strength 0.11
- René Bernards · 1 shared paper, 2022 · strength 0.11
- Sara Mainardi · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.